发明名称 EP4 RECEPTOR INHIBITORS TO TREAT RHEUMATOID ARTHRITIS
摘要 <p>This invention provides a compound of the following formula: or salts thereof, and a compound of the following formula: or salts thereof, wherein Y 1 , Y 2 , Y 3 and Y 4 are independently selected from N, CH, etc.; R 1 is H, C 1-8 alkyl, etc.; A is an optionally substituted benzene or pyridine ring; B is C 2-6 alkylene etc.; W is NH or O; and P is H, protecting group etc.. These compounds are useful as intermediates for the preparation of compounds for the treatment of medical conditions mediated by prostaglamndin such as pain, fever or inflammation, etc.</p>
申请公布号 HU0303766(A3) 申请公布日期 2005.07.28
申请号 HU20030003766 申请日期 2001.10.15
申请人 PFIZER INC., NEW YORK, NEW YORK 发明人
分类号 G01N33/48;A61K31/00;A61K31/4178;A61K31/4184;A61K31/4188;A61K31/427;A61K31/437;A61K31/4439;A61K31/444;A61K31/454;A61K31/4725;A61K31/506;A61K31/52;A61K31/64;A61K45/00;A61P1/00;A61P1/02;A61P1/04;A61P3/10;A61P5/00;A61P7/02;A61P7/04;A61P7/08;A61P9/00;A61P9/10;A61P9/12;A61P9/14;A61P11/02;A61P11/06;A61P13/12;A61P15/04;A61P15/06;A61P17/00;A61P17/02;A61P17/16;A61P19/02;A61P19/06;A61P19/08;A61P19/10;A61P21/00;A61P25/00;A61P25/02;A61P25/04;A61P25/06;A61P25/20;A61P25/28;A61P27/00;A61P27/06;A61P29/00;A61P31/12;A61P31/16;A61P31/18;A61P35/00;A61P35/04;A61P37/00;A61P37/02;A61P37/06;A61P37/08;A61P41/00;A61P43/00;C07D235/06;C07D235/08;C07D235/10;C07D235/12;C07D235/14;C07D235/16;C07D235/30;C07D401/04;C07D401/06;C07D401/12;C07D403/04;C07D403/06;C07D403/12;C07D413/12;C07D417/04;C07D417/12;C07D471/04;C07D473/00;C07D491/04;C07D491/048;C07D491/056;C07D521/00;G01N33/15;G01N33/50 主分类号 G01N33/48
代理机构 代理人
主权项
地址